Fusion proteins - 1 News from the business & finance department by Alveus Therapeutics for the biotechnology industry

Fusion proteins - 1 News from the business & finance department by Alveus Therapeutics for the biotechnology industry

Advertisement

Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing
Streamlined Single-Use TFF Platform for Process Development Through Pilot Manufacturing
Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing
Continuous Low‑pH Virus Inactivation for Integrated Bioprocessing
Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing
Advanced TFF Technology for Enhanced Monoclonal Antibody Concentration and Processing
image description

Alveus Therapeutics launches with $160 million Series A financing

"...Alveus is well positioned to lead the next wave of innovation in obesity therapeutics”

13-Jan-2026 - Alveus Therapeutics Inc., a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, announced its launch with a$159.8 million Series A financing. Proceeds from the financing will support Phase 2 clinical development ofALV-100, the company’s ...

fusion proteins investments metabolic diseases

Advertisement

Maximum binding capacity in ion exchange chromatography
Maximum binding capacity in ion exchange chromatography
3D Raman microscopes with unequalled speed, sensitivity and resolution
3D Raman microscopes with unequalled speed, sensitivity and resolution
Screening and Purification for Large Biomolecules in Multi-Well Plate Design
Screening and Purification for Large Biomolecules in Multi-Well Plate Design
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 28,967 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now